Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Lucia, Pantani"'
Autor:
Carolina Terragna, Andrea Poletti, Vincenza Solli, Marina Martello, Elena Zamagni, Lucia Pantani, Enrica Borsi, Ilaria Vigliotta, Gaia Mazzocchetti, Silvia Armuzzi, Barbara Taurisano, Nicoletta Testoni, Giulia Marzocchi, Ajsi Kanapari, Ignazia Pistis, Paola Tacchetti, Katia Mancuso, Serena Rocchi, Ilaria Rizzello, Michele Cavo
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract The complexity of Multiple Myeloma (MM) is driven by several genomic aberrations, interacting with disease-related and/or -unrelated factors and conditioning patients’ clinical outcome. Patient’s prognosis is hardly predictable, as commo
Externí odkaz:
https://doaj.org/article/b0670f38bd1042f68b22b11a9e85ac10
Autor:
Flavia Bigi, Paola Tacchetti, Alessandro Giorgi, Gaia Mazzocchetti, Vincenza Solli, Simona Barbato, Barbara Sinigaglia, Elena Campanini, Emanuele Favero, Marco Talarico, Michele Puppi, Ilaria Rizzello, Serena Rocchi, Katia Mancuso, Lucia Pantani, Michele Cavo, Elena Zamagni
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
The impact of daratumumab on CD34+ hematopoietic stem cell (HSC) mobilization has recently been a matter of concern. To address this issue, we compared CD34+ HSC-related outcomes in patients with multiple myeloma treated with daratumumab-based quadru
Externí odkaz:
https://doaj.org/article/950b5b65be544c078de9b75b3a23a37d
Autor:
Flavia Bigi, Enrica Manzato, Simona Barbato, Marco Talarico, Michele Puppi, Simone Masci, Ilaria Sacchetti, Roberta Restuccia, Miriam Iezza, Ilaria Rizzello, Chiara Sartor, Katia Mancuso, Lucia Pantani, Paola Tacchetti, Michele Cavo, Elena Zamagni
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 944 (2024)
This systematic review examines the available clinical data on CD34+ cell mobilization, collection, and engraftment in multiple myeloma patients treated with the anti-CD38 monoclonal antibodies daratumumab and isatuximab in clinical trials and in rea
Externí odkaz:
https://doaj.org/article/ca8c80232cb64f9c9adf1c517eb96ad0
Autor:
Enrica Borsi, Ilaria Vigliotta, Andrea Poletti, Gaia Mazzocchetti, Vincenza Solli, Luca Zazzeroni, Marina Martello, Silvia Armuzzi, Barbara Taurisano, Ajsi Kanapari, Ignazia Pistis, Elena Zamagni, Lucia Pantani, Serena Rocchi, Katia Mancuso, Paola Tacchetti, Ilaria Rizzello, Simonetta Rizzi, Elisa Dan, Barbara Sinigaglia, Michele Cavo, Carolina Terragna
Publikováno v:
Cells, Vol 13, Iss 8, p 657 (2024)
Clonal hematopoiesis of indeterminate potential (CHIP) refers to the phenomenon where a hematopoietic stem cell acquires fitness-increasing mutation(s), resulting in its clonal expansion. CHIP is frequently observed in multiple myeloma (MM) patients,
Externí odkaz:
https://doaj.org/article/9eb6935ac05845519040d5dd9482e687
Autor:
Ilaria Vigliotta, Vincenza Solli, Silvia Armuzzi, Ajsi Kanapari, Andrea Poletti, Barbara Taurisano, Ignazia Pistis, Enrica Borsi, Gaia Mazzocchetti, Marina Martello, Ilaria Rizzello, Lucia Pantani, Giulia Marzocchi, Nicoletta Testoni, Elena Zamagni, Mario Terracciano, Valentina Del Monaco, Marianna Garonzi, Nicolò Manaresi, Michele Cavo, Carolina Terragna
Publikováno v:
HemaSphere, Vol 7, p e182325c (2023)
Externí odkaz:
https://doaj.org/article/c282c23606b6444ca6b39d7948fc0300
Autor:
Katia Mancuso, Elena Zamagni, Vincenza Solli, Liliana Gabrielli, Marta Leone, Lucia Pantani, Serena Rocchi, Ilaria Rizzello, Paola Tacchetti, Stefano Ghibellini, Emanuele Favero, Margherita Ursi, Marco Talarico, Simona Barbato, Ajsi Kanapari, Flavia Bigi, Michele Puppi, Carolina Terragna, Enrica Borsi, Marina Martello, Andrea Poletti, Alessandra Scatà, Giuliana Nepoti, Barbara Ruffini, Tiziana Lazzarotto, Michele Cavo
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Long-term kinetics of antibody (Ab) and cell-mediated immune (CMI) response to full anti-SARS-CoV-2 vaccine schedule and booster doses in Multiple Myeloma (MM) patients remain unclear. We prospectively evaluated Ab and CMI response to mRNA vaccines i
Externí odkaz:
https://doaj.org/article/6db24e4256444d06bdb7d131755a0f29
Autor:
Ilaria Vigliotta, Silvia Armuzzi, Martina Barone, Vincenza Solli, Ignazia Pistis, Enrica Borsi, Barbara Taurisano, Gaia Mazzocchetti, Marina Martello, Andrea Poletti, Chiara Sartor, Ilaria Rizzello, Lucia Pantani, Paola Tacchetti, Cristina Papayannidis, Katia Mancuso, Serena Rocchi, Elena Zamagni, Antonio Curti, Mario Arpinati, Michele Cavo, Carolina Terragna
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionMinimal residual disease (MRD) is commonly assessed in bone marrow (BM) aspirate. However, sample quality can impair the MRD measurement, leading to underestimated residual cells and to false negative results. To define a reliable and rep
Externí odkaz:
https://doaj.org/article/45f876f6faa8455682afb6ec6aa42bb9
Autor:
Stefania Oliva, Davine Hofste op Bruinink, Lucie Rihova, Mattia D’Agostino, Lucia Pantani, Andrea Capra, Bronno van der Holt, Rossella Troia, Maria Teresa Petrucci, Tania Villanova, Pavla Vsianska, Romana Jugooa, Claudia Brandt-Hagens, Milena Gilestro, Massimo Offidani, Rossella Ribolla, Monica Galli, Roman Hajek, Francesca Gay, Michele Cavo, Paola Omedé, Vincent H. J. van der Velden, Mario Boccadoro, Pieter Sonneveld
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-9 (2021)
Abstract Minimal residual disease (MRD) by multiparameter flow cytometry (MFC) is the most effective tool to define a deep response in multiple myeloma (MM). We conducted an MRD correlative study of the EMN02/HO95 MM phase III trial in newly diagnose
Externí odkaz:
https://doaj.org/article/fff4989bfcb448fa8d1e3442a6743211
Autor:
Fortunato Morabito, Elena Zamagni, Concetta Conticello, Vincenzo Pavone, Salvatore Palmieri, Sara Bringhen, Monica Galli, Silvia Mangiacavalli, Daniele Derudas, Elena Rossi, Roberto Ria, Lucio Catalano, Paola Tacchetti, Giuseppe Mele, Iolanda Donatella Vincelli, Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Francesco Mendicino, Cirino Botta, Anna Mele, Lucia Pantani, Serena Rocchi, Bruno Garibaldi, Nicola Cascavilla, Stelvio Ballanti, Giovanni Tripepi, Ferdinando Frigeri, Antonetta Pia Falcone, Clotilde Cangialosi, Giovanni Reddiconto, Giuliana Farina, Marialucia Barone, Ilaria Rizzello, Enrico Iaccino, Selena Mimmi, Paola Curci, Barbara Gamberi, Pellegrino Musto, Valerio De Stefano, Maurizio Musso, Maria Teresa Petrucci, Massimo Offidani, Francesco Di Raimondo, Mario Boccadoro, Michele Cavo, Antonino Neri, Massimo Gentile
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The present study aimed to develop two survival risk scores (RS) for overall survival (OS, SRSKRd/EloRd) and progression-free survival (PFS, PRSKRd/EloRd) in 919 relapsed/refractory multiple myeloma (RRMM) patients who received carfilzomib, lenalidom
Externí odkaz:
https://doaj.org/article/558f55d38b4c4a8a985194fbba17f62d
Autor:
Marina Martello, Vincenza Solli, Rosalinda Termini, Ajsi Kanapari, Daniel Remondini, Enrica Borsi, Andrea Poletti, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Gaia Mazzocchetti, Elena Zamagni, Alessandra Merlotti, Paola Tacchetti, Lucia Pantani, Serena Rocchi, Ilaria Rizzello, Katia Mancuso, Michele Cavo, Carolina Terragna
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 20, p 12450 (2022)
DNA microarrays and RNA-based sequencing approaches are considered important discovery tools in clinical medicine. However, cross-platform reproducibility studies undertaken so far have highlighted that microarrays are not able to accurately measure
Externí odkaz:
https://doaj.org/article/4c9f08e932094267b251c9c92b513086